Validity of the ADHD module of the Mini International Neuropsychiatric Interview PLUS for screening of adult ADHD in treatment seeking substance use disorder patients: ADHD screening with MINI-Plus

Palma-Álvarez, Raul Felipe; Barta, Csaba; Carpentier, Pieter Jan; Carruthers, Susan; Crunelle, Cleo L.; Demetrovics, Zsolt; Dom, Geert; Faraone, Stephen V.; Franck, Johan; Johnson, Brian; Kapitány-Fövény, Máté; Kaye, Sharlene; Konstenius, Maija; Matthys, Frieda; Moggi, Franz; Møller, Merete; Schellekens, Arnt; Skutle, Arvid; van de Glind, Geurt; van Emmerik-van Oortmerssen, Katelijne; ... (2023). Validity of the ADHD module of the Mini International Neuropsychiatric Interview PLUS for screening of adult ADHD in treatment seeking substance use disorder patients: ADHD screening with MINI-Plus. Revista de Psiquiatría y Salud Mental, 16(1), pp. 11-15. Elsevier España 10.1016/j.rpsm.2020.04.013

[img]
Preview
Text
1-s2.0-S1888989120300380-main.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).

Download (437kB) | Preview

Objective: This study aims to assess the validity of the ADHD module of the Mini-International Neuropsychiatric Interview (MINI-Plus) in patients with substance use disorders (SUD), using the Conners' Adult ADHD Diagnostic Interview for DSM-IV (CAADID) as the external criterion.
Method: A cross sectional international multi-center study in 10 countries was conducted in treatment seeking SUD patients. A sample of 1263 patients with both MINI-Plus and CAADID was analyzed to determine the psychometric properties of the MINI-Plus.
Results: According to the CAADID, 179 patients (14.2%) met criteria for adult ADHD, whereas according to the MINI-Plus 227 patients (18.0%) were identified as having adult ADHD. Sensitivity of the MINI-Plus ADHD module was 74%, specificity was 91%, positive predictive value was 60% and negative predictive value was 96%. Kappa was 0.60.
Conclusion: The MINI-Plus has acceptable criterion validity for the screening of adult ADHD in treatment seeking SUD patients.
Scientific significance: On the basis of the results, The MINI-Plus may be used for the screening of ADHD in SUD patients.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > University Psychiatric Services > University Hospital of Psychiatry and Psychotherapy

UniBE Contributor:

Moggi, Franz (A)

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1888-9891

Publisher:

Elsevier España

Language:

English

Submitter:

Franz Moggi

Date Deposited:

15 Oct 2020 08:42

Last Modified:

03 Nov 2023 00:10

Publisher DOI:

10.1016/j.rpsm.2020.04.013

PubMed ID:

32561156

Uncontrolled Keywords:

ADHD; Comorbidity; Substance use disorder; MINI; Psychometrics

BORIS DOI:

10.7892/boris.146972

URI:

https://boris.unibe.ch/id/eprint/146972

Actions (login required)

Edit item Edit item
Provide Feedback